Therapeutics and COVID-19: Living guideline, 10 November 2023

Overview

The WHO Therapeutics and COVID-19: living guideline contains the most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. It is available in pdf format {to adapt} (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges.  

The latest version (version 14 published 10 November 2023) contains important updates to recommendations.

Guidelines regarding the use of drugs to prevent (rather than treat) COVID-19 are included in a separate document, WHO Living guideline: Drugs to prevent COVID-19, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).

Guidelines regarding the clinical management of COVID-19 patients are included in a further document, COVID-19 Clinical management: Living guideline, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).

To view previous (now outdated) versions of this guideline, please see the links below:

Version Date Link
1 2 September 2020 accessible as pdf only
2 20 November 2020 access as pdf or via online platform
3 17 December 2020 access as pdf or via online platform)
4 31 March 2021 access as pdf or via online platform)
5 6 July 2021 access as pdf or via online platform)
6 24 September 2021 access as  pdf or via online platform
7 7 December 2021 access as   pdf or via online platform 
8 14 January 2022 access as pdf or via  online platform
9 3 March 2022 access as  pdf or via  online platform
10 22 April 2022 access as  pdf  or via online platform
11 14 July 2022 access as pdf or via online platform
12 16 September 2022 access as  pdf or via online platform
1313 January 2023access as pdf or via online platform

Corrigenda 10 January 2024

Read all languages: Chinese I Russian I French I Spanish I Arabic

 

WHO Team
Communicable Diseases, Emergency Preparedness (WPE), Emerging Diseases Clinical Assessment and Response Network, Guidelines Review Committee, WHO Headquarters (HQ)
Editors
World Health Organization
Number of pages
198
Reference numbers
WHO Reference Number: WHO/2019-nCoV/therapeutics/2023.2
Copyright